Over the past several months, microbiologists and public health experts around the world have been alarmed by the discovery of a gene conferring resistance to colistin, a so-called “last resort” antibiotic. The gene, MCR-1, was discovered in China last
Read More...
Read the complete post at http://healthaffairs.org/blog/2016/04/05/to-fight-antimicrobial-resistance-allow-fda-to-approve-new-drugs-for-limited-populations/
Posted
Apr 05 2016, 10:00 AM
by
Health Affairs BlogHealth Affairs Blog
Filed under: Public Health, Global Health, Quality, Research, Population Health, Featured, Drugs and Medical Technology, FDA, Congress, 21st Century Cures Act, Antibiotic Resistance, Antibiotics, limited-population antibacterial drug, PATH Act, MCR-1